nucynta cr tablet (extended-release)
janssen inc - tapentadol (tapentadol hydrochloride) - tablet (extended-release) - 50mg - tapentadol (tapentadol hydrochloride) 50mg - opiate agonists
nucynta cr tablet (extended-release)
janssen inc - tapentadol (tapentadol hydrochloride) - tablet (extended-release) - 100mg - tapentadol (tapentadol hydrochloride) 100mg - opiate agonists
nucynta cr tablet (extended-release)
janssen inc - tapentadol (tapentadol hydrochloride) - tablet (extended-release) - 150mg - tapentadol (tapentadol hydrochloride) 150mg - opiate agonists
nucynta cr tablet (extended-release)
janssen inc - tapentadol (tapentadol hydrochloride) - tablet (extended-release) - 200mg - tapentadol (tapentadol hydrochloride) 200mg - opiate agonists
nucynta cr tablet (extended-release)
janssen inc - tapentadol (tapentadol hydrochloride) - tablet (extended-release) - 250mg - tapentadol (tapentadol hydrochloride) 250mg - opiate agonists
invega tablet (extended-release)
janssen inc - paliperidone - tablet (extended-release) - 12mg - paliperidone 12mg - atypical antipsychotics
mylan-paliperidone tablet (extended-release)
mylan pharmaceuticals ulc - paliperidone - tablet (extended-release) - 3mg - paliperidone 3mg - atypical antipsychotics
mylan-paliperidone tablet (extended-release)
mylan pharmaceuticals ulc - paliperidone - tablet (extended-release) - 6mg - paliperidone 6mg - atypical antipsychotics
cordran- flurandrenolide tape
almirall, llc - flurandrenolide (unii: 8eul29xuqt) (flurandrenolide - unii:8eul29xuqt) - for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, particularly dry, scaling localized lesions. topical corticosteroids are contraindicated in patients with a history of hypersensitivity to any of the components of these preparations. use of cordran tape is not recommended for lesions exuding serum or in intertriginous areas.
chair, examination/treatment, dental
dentsply sirona pty ltd -